Solti Breast Cancer Research Group
Clinical trials sponsored by Solti Breast Cancer Research Group, explained in plain language.
-
Virus therapy teams up with immune drug to attack breast cancer
Disease control CompletedThis study tested whether injecting a modified virus directly into breast tumors, combined with an immunotherapy drug, could help eliminate remaining cancer cells after standard chemotherapy. The trial involved 28 women with early-stage breast cancer who still had detectable canc…
Phase: EARLY_PHASE1 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated Apr 02, 2026 02:27 UTC
-
New test could unlock precision treatment for tough breast cancers
Disease control CompletedThis study tested whether a specific lab test, called the RAD51-foci score, could predict which patients with advanced HER2-negative breast cancer would benefit most from the drug olaparib. It involved 65 patients, some with known genetic mutations and some without, to see if the…
Phase: PHASE2 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists test Triple-Threat attack on Tough-to-Treat breast cancer
Disease control CompletedThis early-stage study tested adding a new drug called ipatasertib to two standard medications (trastuzumab and pertuzumab) for people with advanced HER2-positive breast cancer that also has a specific genetic change (PIK3CA mutation). The main goal was to find the safest and mos…
Phase: PHASE1 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC